A knowledge-based enterprise since formation, Interpath has invested heavily in research and development of their joint nutraceutical products, which have resulted in ground breaking results in the research of cellular and tissue inflammation including degenerative joint disease (DJD).

Interpath has utilised the latest molecular and cellular biology techniques and technologies, with in-vivo and in-vitro studies providing unequivocal understanding of the science behind their signature products.